Neuphoria Therapeutics (NEUP) Non-Current Assets (2021 - 2026)
Neuphoria Therapeutics' Non-Current Assets came in at $7.64 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 43.6% from $13.55 million a year earlier and down 41.9% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Non-Current Assets (2021 - 2026) Analysis & Trends
Going back to fiscal Q4 2021, Neuphoria Therapeutics' Non-Current Assets data covers 12 quarters.
- Non-Current Assets has declined in each of the last five fiscal years, with a five-year compound annual growth rate of -15.7% (FY2021 to FY2026).
- Going back by fiscal year, Non-Current Assets was $13.55 million in FY2025 (-6.3%), $14.46 million in FY2024 (-5.6%), $15.31 million in FY2023 (-9.0%) and $16.83 million in FY2022 (-6.3%).
- The fiscal Q4 2026 figure represents the lowest quarterly Non-Current Assets in data going back to fiscal Q4 2021.
- Year-over-year, Non-Current Assets has declined for five consecutive quarters, with an average decline of 13.0% over the last five quarters.
- Across the past five years, year-over-year decline in Non-Current Assets ran from 3.5% in fiscal Q3 2026 to 43.6% in fiscal Q4 2026.
- Business Quant data shows NEUP's Non-Current Assets at $13.15 million (Q3 2026), $13.21 million (Q2 2026) and $13.39 million (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 7.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.64 Mn |
| Mar 31, 2026 | 13.15 Mn |
| Dec 31, 2025 | 13.21 Mn |
| Sep 30, 2025 | 13.39 Mn |
| Jun 30, 2025 | 13.55 Mn |
| Mar 31, 2025 | 13.62 Mn |
| Dec 31, 2024 | 13.77 Mn |
| Sep 30, 2024 | 14.49 Mn |
| Jun 30, 2024 | 14.46 Mn |
| Jun 30, 2023 | 15.31 Mn |
| Jun 30, 2022 | 16.83 Mn |
| Jun 30, 2021 | 17.97 Mn |
API Access
Neuphoria Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();